Consensus Indivior PLC London S.E.

Equities

INDV

GB00BN4HT335

Pharmaceuticals

Delayed London S.E. Other stock markets 11:35:04 2025-07-24 EDT			5-day change	1st Jan Change
1,238.00 ^GBX	+1.56%		-.--%	+20.90%

11-14	Camurus Competitor Exits Sweden - Di	FW
11-03	Indivior Presents New Real-World Evidence At AMCP Nexus 2025 Demonstrating Clinical and Economic Benefits of Adherence to Monthly Injectable Buprenorphine	CI

Evolution of the Average Target: Indivior PLC

Evolution of the Target Price: Indivior PLC

Changes in Analyst Recommendations: Indivior PLC

ef5d7c0c8aded3fcc3c37a9dc29.2sN2CpmEQ6Mb4jYgXG2cQj04JW5n2XAqRrhunM1tqO4.46xHTtj2HMkiq2AXAwzxCkV0UyIerxhwK-wC_484xaCFkS5EqtYh1FWyWQ~e349abed8a19352306aee6c9609a5bde

Analysts' recommendations: Indivior PLC

10-15	Indivior PLC Publishes Completes Results from a Multicenter, Open-Label Clinical Trial Published in JAMA Network Open	CI
08-06	HC Wainwright Initiates Indivior at Buy With $28 Price Target	MT
07-28	Jefferies Initiates Coverage on Indivior With Buy Rating, $20 Price Target	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	MERCK KGAA					+20.54%
	KYOWA KIRIN CO., LTD.					+2.43%
	HALOZYME THERAPEUTICS, INC.					+22.98%
	SK BIOPHARMACEUTICALS CO., LTD.					+7.43%
	YUHAN CORPORATION					+27.92%
	BETTA PHARMACEUTICALS CO., LTD.					+32.56%
	SUPERNUS PHARMACEUTICALS, INC.					+30.08%
	Average					+20.56%
	Weighted average by Cap.					+19.20%

See all sector consensus

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

7

Last Close Price

35.79USD

Average target price

37.86USD

Spread / Average Target

+5.78%

High Price Target

41.00USD

Spread / Highest target

+14.56%

Low Price Target

35.00USD

Spread / Lowest Target

-2.21%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

HC Wainwright
Jefferies & Co.

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

7

Last Close Price

35.79USD

Average target price

37.86USD

Spread / Average Target

+5.78%

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

As early as today, start finding the best investment opportunities!